MicroRNA-9 Mediates the Cell Apoptosis by Targeting Bcl2l11 in Ischemic Stroke

Molecular Neurobiology

Volumn 53, Issue 10, 2016, Pages 6809-6817

  Wei, Na ^a   Xiao, Lin ^a   Xue, Rui ^a   Zhang, Dandan ^a   Zhou, Jun ^a   Ren, Huayan ^a   Guo, Si ^b   Xu, Jingjing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Bcl2l11; Ischemic stroke; miR 9

Indexed keywords

MICRORNA 9; PROTEIN BCL 2; BCL2L11 PROTEIN, MOUSE; BIM PROTEIN; GLUCOSE; MICRORNA; MIRN9 MICRORNA, MOUSE; OXYGEN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BCL2L11 GENE; BEHAVIOR DISORDER; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER CONTENT; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC COMPLEMENTATION; IN VITRO STUDY; IN VIVO STUDY; MEDICAL PROCEDURES; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; MOUSE; NERVE CELL; NEUROLOGIC EXAMINATION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PROTEIN BLOOD LEVEL; TRANSLATION REGULATION; TUNEL ASSAY; UPREGULATION; WATER CONTENT; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN SYNTHESIS;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BCL-2-LIKE PROTEIN 11; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE, INBRED C57BL; MICRORNAS; NEURONS; OXYGEN; PROTEIN BIOSYNTHESIS; STROKE; UP-REGULATION;

EID: 84949648235     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9605-4     Document Type: Article

References (41)

1. Johnston SC, Mendis S, Mathers CD (2009) Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8(4):345–354. doi:10.1016/S1474-4422(09)70023-7
2. Ginsberg MD (1997) The new language of cerebral ischemia. AJNR Am J Neuroradiol 18(8):1435–1445
3. Liu S, Levine SR, Winn HR (2010) Targeting ischemic penumbra: part I—from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 3(1):47–55
4. Ramos-Cabrer P, Campos F, Sobrino T, Castillo J (2011) Targeting the ischemic penumbra. Stroke 42(1 Suppl):S7–S11. doi:10.1161/STROKEAHA.110.596684
5. Ferrer I (2006) Apoptosis: future targets for neuroprotective strategies. Cerebrovasc Dis 21(Suppl 2):9–20. doi:10.1159/000091699
6. Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9(3):231–241. doi:10.1038/nrm2312
7. Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355. doi:10.1038/nature02871
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
9. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233. doi:10.1016/j.cell.2009.01.002
10. Ouyang YB, Stary CM, Yang GY, Giffard R (2013) microRNAs: innovative targets for cerebral ischemia and stroke. Curr Drug Targets 14(1):90–101
11. Wu P, Zuo X, Ji A (2012) Stroke-induced microRNAs: the potential therapeutic role for stroke. Exp Ther Med 3(4):571–576. doi:10.3892/etm.2012.452
12. Bhalala OG, Srikanth M, Kessler JA (2013) The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol 9(6):328–339. doi:10.1038/nrneurol.2013.67
13. Vemuganti R (2010) The microRNAs and stroke: no need to be coded to be counted. Transl Stroke Res 1(3):158–160. doi:10.1007/s12975-010-0030-8
14. Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, Jiang X, Wang Y et al (2010) Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30(18):6398–6408. doi:10.1523/JNEUROSCI.0780-10.2010
15. Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J, Chen YE (2010) miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis 38(1):17–26. doi:10.1016/j.nbd.2009.12.021
16. Engel O, Kolodziej S, Dirnagl U, Prinz V (2011) Modeling stroke in mice - middle cerebral artery occlusion with the filament model. Journal of visualized experiments: JoVE (47). doi:10.3791/2423
17. Ying HS, Weishaupt JH, Grabb M, Canzoniero LM, Sensi SL, Sheline CT, Monyer H, Choi DW (1997) Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death. J Neurosci 17(24):9536–9544
18. Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, Balel C, Wang M et al (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140(2):222–234. doi:10.1016/j.cell.2009.12.055
19. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA (2000) Functional assessments in mice and rats after focal stroke. Neuropharmacol 39(5):806–816
20. Wang H, Zhang K, Zhao L, Tang J, Gao L, Wei Z (2014) Anti-inflammatory effects of vinpocetine on the functional expression of nuclear factor-kappa B and tumor necrosis factor-alpha in a rat model of cerebral ischemia-reperfusion injury. Neurosci Lett 566:247–251. doi:10.1016/j.neulet.2014.02.045
21. Keep RF, Hua Y, Xi G (2012) Brain water content. A misunderstood measurement? Transl Stroke Res 3(2):263–265. doi:10.1007/s12975-012-0152-2
22. Yang DJ, Wang XL, Ismail A, Ashman CJ, Valori CF, Wang G, Gao S, Higginbottom A et al (2014) PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons. Cell Death Dis 5:e1096. doi:10.1038/cddis.2014.55
23. Xu J, Liu Y, Guo S, Ma S, Xiao L, Wei N, Xue R (2015) Expression profile of MiR-128 in the astrocytoma patients and cell lines. Mol Neurobiol. doi:10.1007/s12035-015-9401-1
24. Liu Y, Zhang J, Han R, Liu H, Sun D, Liu X (2015) Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic stroke. J Clin Neurosci 22(2):291–295. doi:10.1016/j.jocn.2014.05.042
25. Coolen M, Katz S, Bally-Cuif L (2013) miR-9: a versatile regulator of neurogenesis. Frontiers in cellular neuroscience 7:220. doi:10.3389/fncel.2013.00220
26. Deo M, Yu JY, Chung KH, Tippens M, Turner DL (2006) Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn 235(9):2538–2548. doi:10.1002/dvdy.20847
27. Pietrzykowski AZ, Friesen RM, Martin GE, Puig SI, Nowak CL, Wynne PM, Siegelmann HT, Treistman SN (2008) Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59(2):274–287. doi:10.1016/j.neuron.2008.05.032
28. Shibata M, Kurokawa D, Nakao H, Ohmura T, Aizawa S (2008) MicroRNA-9 modulates Cajal-Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium. J Neurosci 28(41):10415–10421. doi:10.1523/JNEUROSCI.3219-08.2008
29. Zhao C, Sun G, Li S, Shi Y (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 16(4):365–371. doi:10.1038/nsmb.1576
30. Rink C, Khanna S (2011) MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 43(10):521–528. doi:10.1152/physiolgenomics.00158.2010
31. Jeyaseelan K, Lim KY, Armugam A (2008) MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39(3):959–966. doi:10.1161/STROKEAHA.107.500736
32. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733–1741. doi:10.1373/clinchem.2010.147405
33. Weiland M, Gao XH, Zhou L, Mi QS (2012) Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 9(6):850–859. doi:10.4161/rna.20378
34. Liu XS, Chopp M, Zhang RL, Tao T, Wang XL, Kassis H, Hozeska-Solgot A, Zhang L et al (2011) MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PloS One 6(8):e23461. doi:10.1371/journal.pone.0023461
35. Buller B, Chopp M, Ueno Y, Zhang L, Zhang RL, Morris D, Zhang Y, Zhang ZG (2012) Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation. Glia 60(12):1906–1914. doi:10.1002/glia.22406
36. Li JS, Yao ZX (2012) MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. Mol Neurobiol 45(1):200–212. doi:10.1007/s12035-011-8231-z
37. O’Connor L, Strasser A, O’Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17(2):384–395. doi:10.1093/emboj/17.2.384
38. Sionov RV, Vlahopoulos SA, Granot Z (2015) Regulation of Bim in health and disease. Oncotarget 6(27):23058–23134
39. Strasser A (2005) The role of BH3-only proteins in the immune system. Nat Rev Immunol 5(3):189–200. doi:10.1038/nri1568
40. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Molecular cell 17(4):525–535. doi:10.1016/j.molcel.2005.02.003
41. Marani M, Tenev T, Hancock D, Downward J, Lemoine NR (2002) Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22(11):3577–3589